Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG

Approval Number

SIN15864P

Drug Name

ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG

Product Name

ABALAM ABACAVIR SULFATE & LAMIVUDINE TABLETS 600/300 MG

Approval Date

December 2, 2019

Registrant

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Licence Holder

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Regulatory Information

Registrant

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Licence Holder

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

J05AR02

ATC Item Name

lamivudine and abacavir

Manufacturer Information

Pharmaceutical Manufacturer

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Manufacturers

HETERO LABS LIMITED

Active Ingredients

Ingredient Name

Abacavir Sulfate 702.762 mg eqv. Abacavir

Strength

600.0 mg

Drug MonographAbacavir

Ingredient Name

Lamivudine

Strength

300.000 mg

Drug MonographLamivudine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy